The IPSS score is an internationally recognized standard for determining the severity of symptoms in patients with benign prostatic hyperplasia. The IPSS score is a subjective reflection of the severity of symptoms in the lower urinary tract of patients with BPH, and it does not correlate significantly with the maximum urinary flow rate, residual urine volume, or prostate volume. The IPSS score classifies patients as follows: (total score 0-35) Mild symptoms 0-7 Moderate symptoms 8-19 Severe symptoms 20-35 QOL score (0-6) is a subjective measure of how patients feel about their current level of lower urinary tract symptoms over their lifetime. This is why it is also known as the distress score. Although these two scores do not fully summarize the impact of lower urinary tract symptoms on the quality of life of BPH patients, they provide a platform for communication between the physician and the patient and allow the physician to gain a good understanding of the patient’s disease status. 2 , Treatment of prostatic hyperplasia The treatment of BPH consists of watchful waiting, medication and surgical treatment. 2, 1, watchful waiting Patients with mild lower urinary tract symptoms (IPSS score ≤ 7) and patients with moderate or more symptoms (IPSS score ≥ 8) whose quality of life has not yet been significantly affected can be treated with watchful waiting. Eighty-five percent of patients who received watchful waiting remained stable at 1 year of follow-up, and 65% had no clinical progression at 5 years. The short-term goal of pharmacotherapy for patients with BPH is to relieve the lower urinary tract symptoms and the long-term goal is to delay the clinical progression of the disease and prevent comorbidities. The overall goal of drug therapy for BPH is to reduce the side effects of drug therapy while maintaining a high quality of life for patients. Commonly used drugs are highly selective α-blockers, 5α-reductase inhibitors and pollen-based agents. 2, 3, Surgical treatment Patients with severe BPH or those whose lower urinary tract symptoms have significantly affected their quality of life may opt for surgical treatment, especially if medication is ineffective or if they refuse to accept medication, surgical treatment can be considered. The most common surgical method is transurethral electrical (vaporization) resection of the prostate (TURP), which is internationally regarded as the “gold standard” for the treatment of prostate hyperplasia.